Clinical Trial Update: Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the use of radiotherapy in metastatic esophageal cancer patients who are responding to a PD-1 inhibitor plus chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Neoplasm Metastatic, Esophageal Cancer Stage IVb | Phase 2 | Status: RECRUITING